packagePaclitaxelPoliglumex

paclitaxel poliglumex

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Paclitaxel poliglumex is an investigational taxane-based anticancer agent developed as a modified form of the chemotherapy drug paclitaxel for treating cancer. It has not been approved and remains investigational, with no authorisation in the European Union or elsewhere.

Summary written by glm-5.3-flash from Wikidata Q72499389 and the WHO ATC classification; not checked by a person.

name:paclitaxel poliglumex
ATC codes:L01CD03
DrugBank:DB13809
Wikidata:Q72499389

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown